SOD1 and metabolic dysfunction-associated steatotic liver disease: As shown in Table 3, NAFLD rats exhibited an imbalance in hepatic redox status, as evidenced by a substantial (p < 0.05) increment in the hepatic MDA concentration and marked decreases in sTAC, hepatic SOD, GSH, and CAT concentrations compared to the control group.